Pathological examination and IHC analysis provide conclusive evidence for diagnosis, in which the tumor’s positive response to thyroid-specific markers, such as TTF-1, PAX8, and thyroglobulin, is key to diagnosis. The gene discussed is TTF1; the disease is thyroid gland disorder.